The genomic landscape of small intestine neuroendocrine tumors.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Investigation

• Publication date

  2013-06-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI67963PMID 23676460PMCID PMC3668835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition

  2012cited by this paper
• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

  2012cited by this paper
• Complexities of TGF-β Targeted Cancer Therapy

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.

  2012cited by this paper
• EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets

  2012cited by this paper
• Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells.

  2011cited by this paper
• SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.

  2011cited by this paper
• Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

  2011cited by this paper
• DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

  2011influential reference
• Detection of somatic copy number alterations in cancer using targeted exome capture sequencing.

  2011cited by this paper
• Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

  2011cited by this paper
• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  2011cited by this paper
• WHO Classification of Tumours of the Digestive System

  2010cited by this paper
• Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.

  2010influential reference
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Recurring mutations found by sequencing an acute myeloid leukemia genome.

  2009cited by this paper
• High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids.

  2009cited by this paper
• High‐resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss

  2008cited by this paper
• Allelic alterations in well‐differentiated neuroendocrine tumors (carcinoid tumors) identified by genome‐wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors

  2008cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor–β1‐mediated regulatory abnormalities including up‐regulation of C‐Myc and MTA1

  2007cited by this paper
• The molecular genetics of gastroenteropancreatic neuroendocrine tumors

  2005cited by this paper
• Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

  2003cited by this paper
• Autocrine growth inhibition by transforming growth factor β-1 (TGFβ-1) in human neuroendocrine tumour cells

  2003cited by this paper
• Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation

  2001cited by this paper
• Investigation

  2000cited by this paper

• Single-Cell Comparison of Small Intestinal Neuroendocrine Tumors and Enterochromaffin Cells from Two Patients

  2026cites this paper
• Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine neoplasms.

  2026cites this paper
• Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs)

  2025cites this paper
• Integrated genomic analysis of small intestinal neuroendocrine tumors provides further insights into molecular subgroups and identifies putative driver genes

  2025cites this paper
• Molecular alterations in high‐grade neuroendocrine tumors of the small intestine

  2025cites this paper
• Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications

  2025cites this paper
• Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors

  2025cites this paper
• A case report of primary small bowel neuroendocrine tumor with large metastatic lymph node at root of mesentery with tumor fibrosis

  2025cites this paper
• Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors

  2025influential citation
• Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors

  2025cites this paper
• Small Bowel Neuroendocrine Tumors: An Update.

  2025cites this paper
• Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine neoplasms

  2025cites this paper
• Current Clinical Trial Landscape of Gastroenteropancreatic Neuroendocrine Tumors: A New Era of Landmark Trials

  2025cites this paper
• Concurrent Biopsy During Liver-Directed Therapy: Considerations, Techniques, and Expanding Role in Clinical Practice

  2025cites this paper
• Small intestinal neuroendocrine tumors lack early genomic drivers, acquire DNA repair defects and harbor hallmarks of low REST expression

  2025cites this paper
• Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review)

  2025cites this paper
• Developing a predictive model for metastatic potential in pancreatic neuroendocrine tumor.

  2024cites this paper
• A Comprehensive Overview of NF1 Mutations in Iranian Patients

  2024cites this paper
• Pancreatic and Ileal Neuroendocrine Tumors

  2024cites this paper
• Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

  2024cites this paper
• Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors

  2024cites this paper
• Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments

  2024cites this paper
• Whole-exome sequencing reveals novel genomic signatures and potential therapeutic targets during the progression of rectal neuroendocrine neoplasm

  2024cites this paper
• Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures.

  2024cites this paper
• An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects

  2024cites this paper
• Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?

  2024cites this paper
• Update in the management of gastroenteropancreatic neuroendocrine tumors

  2024cites this paper
• Testicular Primary Well-Differentiated Neuroendocrine Tumor: Clinicopathologic, Immunohistochemical, and Molecular Characterization of Two Patients

  2024cites this paper
• Pancreatic Neuroendocrine Tumor: The Case Report of a Patient with Germline FANCD2 Mutation and Tumor Analysis Using Single-Cell RNA Sequencing

  2024cites this paper
• Whole-exome sequencing of rectal neuroendocrine tumors

  2023cites this paper
• The Molecular Biology of Midgut Neuroendocrine Neoplasms

  2023cites this paper
• Neuroendocrine Neoplasms: Genetics and Epigenetics.

  2023cites this paper
• MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms

  2023cites this paper
• Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms

  2023cites this paper
• Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.

  2023cites this paper
• NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?

  2023cites this paper
• Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups.

  2023cites this paper
• Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2

  2023cites this paper
• Proposed oncogenesis of mixed adenocarcinoma and poorly differentiated neuroendocrine carcinoma in Crohn's disease: A comparative morphomolecular study

  2023cites this paper
• Long-term organoid culture of a small intestinal neuroendocrine tumor

  2023cites this paper
• Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors – Experiences from a tertiary referral center

  2023cites this paper
• Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype

  2023cites this paper
• Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes

  2023cites this paper
• Multiomic sequencing of paired primary and metastatic small bowel carcinoids

  2023cites this paper
• Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms

  2023cites this paper
• Genetic alterations of GI‐NECs involving three main signaling pathways

  2023cites this paper
• Myeloid leukemia factor 1: A “double-edged sword” in health and disease

  2023cites this paper
• The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms

  2023cites this paper
• Prioritization of Fluorescence In Situ Hybridization (FISH) Probes for Differentiating Primary Sites of Neuroendocrine Tumors with Machine Learning

  2023cites this paper
• A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.

  2023cites this paper
• The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities

  2022cites this paper
• Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors

  2022cites this paper
• Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Cancer

  2022cites this paper
• Case Report: Precision genetic diagnosis in a case of Dyggve-Melchior-Clausen syndrome reveals paternal isodisomy and heterodisomy of chromosome 18 with imprinting clinical implications

  2022cites this paper
• Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration

  2022cites this paper
• Novel therapeutic approaches in gep-nets based on genetic and epigenetic alterations.

  2022cites this paper
• Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors

  2022cites this paper
• Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging

  2022cites this paper
• Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast

  2022cites this paper
• Tissue and cell specific properties of enterochromaffin cells affect the fate of tumorigenesis toward non-endocrine adenocarcinoma of the small intestine.

  2022cites this paper
• Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis

  2022cites this paper
• Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors

  2022cites this paper
• DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors

  2022cites this paper
• Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin

  2022cites this paper
• Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues

  2022cites this paper
• Jejunoileal Neuroendocrine Tumors

  2021cites this paper
• Pathology of Neuroendocrine Neoplasms in the Digestive System

  2021cites this paper
• Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

  2021cites this paper
• Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors

  2021influential citation
• Drug Development in Neuroendocrine Tumors: What Is on the Horizon?

  2021cites this paper
• Molecular Biology of Neuroendocrine Tumors

  2021cites this paper
• Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?

  2021cites this paper
• Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations

  2021cites this paper
• Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms

  2021cites this paper
• Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

  2021cites this paper
• Integrative proteomic characterization of trace FFPE samples in early-stage gastrointestinal cancer

  2021cites this paper
• The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy

  2021cites this paper
• Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors

  2021cites this paper
• Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up

  2021cites this paper
• EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine

  2021cites this paper
• Gastrin: From Physiology to Gastrointestinal Malignancies

  2021influential citation
• Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors

  2021cites this paper
• Genetic Drivers of Ileal Neuroendocrine Tumors

  2021influential citation
• Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.

  2021cites this paper
• The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

  2021cites this paper
• Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors.

  2021cites this paper
• The emerging clinical relevance of genomic profiling in neuroendocrine tumours

  2021cites this paper
• Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours

  2021cites this paper
• The evolving molecular landscape of intestinal and pulmonary neuroendocrine tumours

  2021cites this paper
• Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014

  2020cites this paper
• Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors

  2020influential citation
• Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor

  2020cites this paper
• Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors

  2020cites this paper
• [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].

  2020cites this paper
• Carcinoid Tumors: Past, Present, and Future

  2020cites this paper
• An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin

  2020cites this paper
• A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

  2020cites this paper
• Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine

  2020cites this paper
• Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases

  2020cites this paper
• IGF2 drives formation of ileal neuroendocrine tumors in patients and mice.

  2020cites this paper